Literature DB >> 19249851

Quantitative differential proteome analysis in an animal model for human melanoma.

Katrin Lokaj1, Svenja Meierjohann, Claudia Schütz, Janka Teutschbein, Manfred Schartl, Albert Sickmann.   

Abstract

In fish of the genus Xiphophorus, different grades of pigment cell lesions from nevi to melanoma can be gained by simple crossbreeding. With this model, one can easily access tissues of different malignancies from animals with highly identical genetic background. To find protein expression differences between healthy, benign and malignant tissues, we performed 2D PAGE and DIGE and found among regulated proteins antioxidant proteins that were overexpressed with increasing malignancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249851     DOI: 10.1021/pr800578a

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  11 in total

1.  Proteomic analyses of the Xiphophorus Gordon-Kosswig melanoma model.

Authors:  Amy N Perez; Lee Oehlers; Shelia J Heater; Rachell E Booth; Ronald B Walter; Wendi M David
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-06-06       Impact factor: 3.228

2.  Expression signatures of early-stage and advanced medaka melanomas.

Authors:  Barbara Klotz; Susanne Kneitz; Martina Regensburger; Lena Hahn; Michael Dannemann; Janet Kelso; Birgit Nickel; Yuan Lu; William Boswell; John Postlethwait; Wesley Warren; Manfred Kunz; Ronald B Walter; Manfred Schartl
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2017-11-21       Impact factor: 3.228

3.  Conserved expression signatures between medaka and human pigment cell tumors.

Authors:  Manfred Schartl; Susanne Kneitz; Brigitta Wilde; Toni Wagner; Christiaan V Henkel; Herman P Spaink; Svenja Meierjohann
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

4.  The PeptideAtlas of a widely cultivated fish Labeo rohita: A resource for the Aquaculture Community.

Authors:  Panga Jaipal Reddy; Nevil Pinto; Mehar Un Nissa; Zhi Sun; Biplab Ghosh; Robert L Moritz; Mukunda Goswami; Sanjeeva Srivastava
Journal:  Sci Data       Date:  2022-04-13       Impact factor: 6.444

Review 5.  Hypoxia-independent drivers of melanoma angiogenesis.

Authors:  Svenja Meierjohann
Journal:  Front Oncol       Date:  2015-05-05       Impact factor: 6.244

6.  In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells.

Authors:  C Leikam; A L Hufnagel; C Otto; D J Murphy; B Mühling; S Kneitz; I Nanda; M Schmid; T U Wagner; S Haferkamp; E-B Bröcker; M Schartl; S Meierjohann
Journal:  Cell Death Dis       Date:  2015-04-02       Impact factor: 8.469

Review 7.  Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.

Authors:  Jerry D Monroe; Faiza Basheer; Yann Gibert
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

8.  Germ cell and tumor associated piRNAs in the medaka and Xiphophorus melanoma models.

Authors:  Susanne Kneitz; Rasmi R Mishra; Domitille Chalopin; John Postlethwait; Wesley C Warren; Ronald B Walter; Manfred Schartl
Journal:  BMC Genomics       Date:  2016-05-17       Impact factor: 3.969

9.  The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression.

Authors:  Christina Jessen; Julia K C Kreß; Apoorva Baluapuri; Anita Hufnagel; Werner Schmitz; Susanne Kneitz; Sabine Roth; André Marquardt; Silke Appenzeller; Carsten P Ade; Valerie Glutsch; Marion Wobser; José Pedro Friedmann-Angeli; Laura Mosteo; Colin R Goding; Bastian Schilling; Eva Geissinger; Elmar Wolf; Svenja Meierjohann
Journal:  Oncogene       Date:  2020-09-25       Impact factor: 9.867

Review 10.  Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies.

Authors:  Stefania Pizzimenti; Simone Ribero; Marie Angele Cucci; Margherita Grattarola; Chiara Monge; Chiara Dianzani; Giuseppina Barrera; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2021-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.